Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Methotrexate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Methotrexate 30mg/1.2ml inj pre-filled syringes
0801030P0AACGCG
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 30mg/1.5ml inj pre-filled syringes
1001030U0AABRBR
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 32.5mg/1.3ml inj pre-filled syringes
0801030P0AAEAEA
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 35mg/1.4ml inj pre-filled syringes
0801030P0AADNDN
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 4mg/5ml oral liquid
1001030U0AAAUAU
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 500mg/20ml solution for injection vials
0801030P0AAAKAK
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 50mg/2ml inj pre-filled syringes
0801030P0AADVDV
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 50mg/5ml oral liquid
1001030U0AAANAN
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 5g/200ml solution for infusion vials
0801030P0AACUCU
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 5g/50ml solution for infusion vials
0801030P0AACSCS
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 5mg/0.2ml inj pre-filled syringes
0801030P0AABPBP
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 5mg/5ml oral liquid
1001030U0AAAFAF
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 6mg/5ml oral liquid
1001030U0AAAWAW
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 7.5mg/0.75ml inj pre-filled syringes
1001030U0AAAZAZ
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 750micrograms/5ml oral liquid
1001030U0AAAQAQ
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 7mg/5ml oral liquid
1001030U0AAAMAM
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 8mg/5ml oral liquid
1001030U0AAAPAP
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 10mg/1ml solution for injection pre-filled syringes
1001030U0BEACBB
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 12.5mg/0.25ml inj pre-filled syringes
1001030U0BEALBK
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 15mg/1.5ml inj pre-filled syringes
1001030U0BEADBC
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 20mg/2ml solution for injection pre-filled syringes
1001030U0BEABBA
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 22.5mg/0.45ml inj pre-filled syringes
1001030U0BEANBM
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 25mg/2.5ml inj pre-filled syringes
1001030U0BEAEBD
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 27.5mg/0.55ml inj pre-filled syringes
1001030U0BEAPBN
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Metoject 30mg/0.6ml inj pre-filled syringes
1001030U0BEAKBJ
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.